• Hold hospital boards accountable for quality. This accountability would be equivalent to requirements for proper financial stewardship, subject to penalties for failure to discharge it properly, requiring them to implement mechanisms for its enforcement, possibly as a condition of participation in Medicare.
• Create a Medicare-based national initiative to reduce preventable hospital admissions and readmissions, and work with hospitals to help mitigate the financial burden of that transition.
• Expand hospice care through support to community-based programs, especially in small communities, and proper redesign of Medicare and Medicaid payment systems to limit expensive treatments that do little to improve the quality of life.
for Economic Cooperation and Development. The next most costly nation spent 60 percent of that per capita, and several nations whose systems outperform ours in satisfaction and health status spent even less. bill, but many calculate it to be on the order of 30 percent of total production costs. Some say it is even higher.
The United States, in general, also leads the world in health care research. Biotechnical innovations and bioscience are successful in many nations, but no other nation has an organization that in scale, excellence, and achievement matches the National Institutes of Health or the Centers for Disease Control and Prevention.
Despite this excellence in health care technology, abundance, and research, the U.S. health care system in numerous other crucial dimensions significantly underperforms, both in absolute terms and relative to other developed nations and across states in areas such as injury rates of patients in care, absence of needed care, overuse of unnecessary and sometimes harmful care, continuity failures for the chronically ill, and racial and socioeconomic inequity.
The Institute of Medicine outlines six "aims for improvement" when it comes to health care system performance: safety, effectiveness, patientcenteredness, timeliness, efficiency, and equity (see the book's introduction for more details). The IOM report, "Crossing the Quality Chasm,"
summarizes evidence on major problems in every one of these six dimensions of health care quality, and suggests that the United States can significantly improve its health care quality in every dimension with the aid of already-available technology. These successes suggest that the federal government-as both a payer and provider of care-can catalyze focused health system improvements.
It can lead through example as a care provider, have direct influence as a purchaser, and provide metrics for quality measurement and goal-setting.
The National Quality Forum has made significant gains in certifying evi- 
The fuTure of healTh Care QualITy
The pursuit of health care quality can be divided into two broad components: improving the quality of care for individuals, especially for people with acute and severe illnesses; and reshaping our health care systems to improve care across the population.
Each of these pursuits requires a different set of actors and a different set of changes in the regulatory and financing environment. Addressing the needs of the population as a whole will be more difficult than helping individuals, because it requires more structural changes and will mobilize stronger opposition from stakeholders in the status quo. But a new administration has opportunities to help on both agendas.
Improving individual care
The new administration should use the Institute of Medicine's six dimensions of quality to set its aims for improving individual health care. Most care providers, even large hospitals, still lack both the will and competence to improve the processes of care, and most health care boards of trustees and senior executives view the improvement of care as a strategic agenda at best secondary to maintaining revenues and stabilizing public reputation. The federal government should therefore push hospitals, nursing homes, and office-based practices to make the changes in care processes they need to achieve much higher levels of reliability and teamwork, and to invite patients and families much more into positions of influence and control over their own care.
The next president in his first term should set specific goals that include:
1. Reducing medically induced injuries to patients in hospitals by a specific target amount. A 20 percent reduction in four years is probably technically achievable.
2. Measurably improving the delivery of evidence-based care for a list of major chronic and acute illnesses in all relevant settings.
3. Supporting and expanding the use of shared decision-making supports for patients and families facing difficult choices among treatment options.
4. Identifying and reducing overuse of specific, ineffective health care procedures in hospitals and other acute care settings.
These overall goals for improvement cannot be achieved through a single policy change or action on the part of the federal government alone. A range of specific policies and regulatory actions, described later in this chapter, can increase the odds of success.
Improving care across the population
Improving individual care is important, but it cannot solve the concertmaster problems of better health outcomes and lower costs. The best long-term strategy for affordability-and making universal health care economically feasible-is to improve care systems. This means focusing on changes that affect structures and processes of care for the entire population-patterns well beyond individual, case-by-case improvements.
Systematic factors and preconditions drive excess treatment, leading to avoidable and wasteful costs. These factors include inadequate sec-ondary prevention of complications in chronic disease care; over-reliance on technologies that are unproven or have very marginal value;
administrative waste due to complexity and variation in billing, licensure, and record-keeping; the outmoded, defect-ridden, and inefficient paper medical record; and inefficiencies and inequities in the malpractice liability system.
Oversupply and fragmentation-the absence of integrated structures, processes, and behaviors, especially in the care of the chronically ill-are the two overriding characteristics that explain many of the problems with the current U.S. health care system. And neither can be mitigated substantially by focusing on the care of individuals alone.
Health providers can achieve sensible cost reductions while maintaining or improving the care experience of patients and families, but incentives are not aligned to get that done. One important example is the very high rate of readmission of Medicare patients who are discharged from the hospital after experiencing congestive heart failure. Congestive heart failure is the most common reason for admission among Medicare beneficiaries-almost 1 million admissions per year-and about 40 percent of the congestive heart failure patients discharged are readmitted within 90 days. This is nearly pure waste from the viewpoint of both patients and science.
Clinical researchers have known for over a decade that a well-designed chronic care support system can reduce that readmission rate by over 85 percent. The potential cost savings for Medicare would be enormous, and patients and families would be better off in terms of health and functional status. Achieving this result requires a combination of team-based care, home health care outreach, patient and family education, simple forms of home-based monitoring, proper pharmaceutical management, and self-care skills. All of this could be arranged by a hospital, in theory, if it cooperated and shared information with local physicians and agencies, and extended its efforts to the period after discharge. The result would be cost reductions for Medicare, better health for patients, and a major revenue loss to the hospital.
The catch is that more effective a hospital is, the worse its finances would become. Beds would lie empty, whereas hospital leaders and business plans are currently rewarded financially for keeping beds full by increasing admissions. Some hospitals, despite this toxicity of reimbursement, work hard on better chronic disease care and secondary pre- it is a structural problem in the design of the financing and delivery system itself. When it is not in health provider's interest to remove waste, they do not.
This lack of incentive, in our opinion, explains more than anything else why and how some European systems and a few U.S. systems are able to achieve better care at a far lower cost. Their structures and financing help them think and act in population terms. They can, and want to, integrate care across boundaries. They want to limit capital growth, rather than relying on it for revenue. They work with a sense of limited resources, and avidly seek to remove waste, because with capped resources, waste reduction is "internal" revenue, available for reinvestment. They can essentially harvest and reinvest the financial gains of reducing ineffective care. Public health investments and secondary prevention systems that avoid the need for high-technology services and hospital days become the "winners," not "losers," in these systems. In short, integrated care structures and population-based budgets provide the preconditions for far higher value and lower cost.
A strategy to address health quality must address the underlying payment incentives that influence clinical decisions. We must move away from treating only acute care needs and move to a more holistic approach. One recent framing of the needed social agenda is the so-called "triple aim":
improve care for individuals, improve the health of populations, and stabilize or reduce the per-capita cost of health care for the population. conducting research on the comparative effectiveness of treatments and procedures; and leading a major research program into redesigning health care systems and processes to achieve better individual care, better population health, and lower per capita costs. AHRQ should also continue to improve the annual National Quality Report and the National Health Disparities report, which should be received formally by the president and Congress, and responded to publicly each year by the president.
hold hospital boards legally accountable for quality and safety improvements.
The new administration should work with Congress to consider enacting a firm legal and regulatory requirement that hospital boards would have to "continually improve patient care quality and safety." This would be equivalent to existing requirements for proper financial stewardship, subject to penalties for failure to discharge it properly, and should include mechanisms for its enforcement, or at least as a condition of participation in Medicare.
support no-fault malpractice demonstration projects. The federal government should support statewide experiments in no-fault malpractice insurance, subject to the conditions of full disclosure, prompt compensation, apology, and systemic learning and improvement. No-fault malpractice policy would adapt to health care settings the basic principles of worker compensation programs, which focus less on judicial contests and findings of fault than on administrative procedures for prompt and fair compensation of injured parties. This would, admittedly, be a reach for the federal government, since malpractice liability is largely a matter of state-level policy, not federal policy. The new administration should therefore seek demonstration authority under which the federal government can try to help or influence a trend toward no-fault regimes.
The strongest lever available for truly altering our health care quality is moving away from paying providers on a transactional basis, and changing payments so that provider incentives align with better and more efficient care, especially for people with chronic illnesses.
The United States has experimented modestly in the past with integrated care systems under population-based budgets. The emergent format was the Health Maintenance Organization, or HMO, which was originally conceived by the founders of classical models such as Kaiser-Permanente in California, Group Health Cooperative of Puget Sound, and Health Partners in Minneapolis. In their heyday, which was approximately the 1960s and 1970s, these classic models significantly outperformed the fragmented majority of plans.
HMOs' popularity declined not because the classical HMO models failed at first, but because the HMO label was expanded in use to include a collection of restrictive, insurance-based models which did not really manage care, but managed rules and restrictions and the flow of money.
The good forms of managed care, like the Kaiser Permanente-type model, still exist, but these programs are the exception rather than the rule.
Less integrated health plans have difficulty changing the behavior of physicians and hospitals because they pay on an episodic basis. At worst, they may emphasize a restrictive role for primary care physicians, making them gatekeepers to limit care and keep costs low, rather than care coordinators with responsibility for making sure patients' providers are coordinated such that each individual patient receives efficient, timely, and effective treatment. The growth in these less integrated plans reflects the difficulties in aligning payment incentives to produce quality care.
High-performing health care systems in other developed nations tend, by and large, to "manage care" in the original sense: plan and coordinate it, maintain flexibility as to how resources are used, measure success primarily through health and satisfaction, be subject to overall budget limits, and unify the experience of patients across boundaries.
This level of coordination will be difficult to achieve given our current fragmented system with many different payers and many individuals managed by several different payers. Nonetheless, policy changes could be made to promote a fee-for-service model that contains strong case-management and disease-management tools and that financially rewards pro-viders for services that improve quality. More integrated payment models are also needed in which providers, hospitals, and other health care providers are paid through means other than for episodic care. These changes are fundamental to any quality improvement effort.
Assuming major payment changes (see chapter 4 on payment for more information), the new administration will have to take a larger role in supporting wise and useful standardization in the private care system, a role largely played today by the states. Three ideas underlie all of these proposed changes: strengthening information technologies, especially electronic patient records, so that they become our nation's norm, not the exception; developing systems of integrated care for people with chronic illness across the entire continuum of care; and aligning financial incentives and payment streams to encourage, reward, and support effective care of the chronically ill. To accomplish these goals, the new administration should undertake five new initiatives: These changes would also greatly reduce the amount of staff time devoted to deciphering each payer's billing practices so that providers could focus more of their time and attention on delivering patient care.
Developing electronic medical records that are accessible by a patient's treating physician or facility will be an important asset in improving quality. We ultimately need a system that guards confidentiality and is under the patient's control, but that is still accessible, with the patient's permission, to anyone treating the patient-physicians, providers, facilities, pharmacies, and others. Systems will achieve better dividends if an emergency department doctor does not have to rely on a patient's memory of treatment, or if uniform medical records follow chronically ill patients wherever they seek care. Electronic health records would aid in reducing duplicative or conflicting treatments and decreasing the likelihood of prescribing incompatible medications, avoiding adverse drug events, and reducing medication errors.
support large-scale chronic disease registries. The federal government should promote the development and deployment of large-scale chronic disease registries that would, with major safeguards for confidentiality, allow health care providers to better manage patients across time and among institutions, as well as assess progress in clinical outcomes and total costs. Requiring electronic medical records could facilitate this change.
The new administration will need to develop a system to address privacy concerns over collecting these statistics. Private plans also object to data collection because of the administrative costs associated with managing it while ensuring confidentiality. The White House and Congress could use positive or negative incentives to obtain these data from private insurers, Medicare, Medicaid, and other federal health care programs.
Implement comparative effectiveness studies for treatments. The new administration should ensure that providers have the most up-to-date information about clinical research and effective treatments by establishing a neutral entity, free of commercial and political pressure, whose mission would be to compare procedures, drugs, and other treatments and to determine which course of treatment is most effective for different conditions. The federal government would also need to help and encourage providers to use the most effective treatments, and not simply the ones with the highest reimbursement levels or those believed, without evidence, to be more effective than less costly alternatives.
A critical component in a system using comparative effectiveness research is to assure that clinicians are educated about differences among procedures, drugs, and treatment alternatives, and that their management strategies reflect the most current knowledge. One of the major causes of health disparities among racial minorities stems from beneficiaries not getting adequate treatment at the right time-not getting needed preventive care, not being screened for conditions, and not getting the proper treatment when they do receive a diagnosis. This difference can be partially explained by a disproportionate lack of insurance, but racial disparities also persist among the insured. The federal government could help accelerate quality of care improvements through increased funding, which is a perennial issue, and helping to shift political will. These changes are attainable with federal leadership. Improving care and health across the population Improving quality for the entire health care system across the continuum and aiming for an overall healthier population requires more significant structural changes. The needed policy initiatives create losers, as well as winners, mainly as acute care needs decline in favor of primary care and integrated services. Specialist and acute-care provider opposition to these proposals could therefore be strong. If structural changes are not properly implemented, they could easily lead to a cost shift from Medicare to providers, plans, or both, and they would fail to improve the quality of care.
The most serious threat to health quality improvements would be "gaming" by plans and providers, who could recruit and enroll members who need the care least, leaving expensive subgroups to others, a problem that is already far too common in some Medicare Advantage plans. Policies aimed at restructuring and improving care for populations will require more effort to implement, but could fundamentally change both the true costs and quality of our health care delivery if successful.
Trying to simplify billing procedures would generate some opposition because of the costs associated with making changes. Convincing all payers to move to a uniform system will take time, money, and political will.
The federal government will need to offer some incentives or support to private payers to make these changes. There is emerging consensus that electronic health records and comparative effectiveness are needed to improve health care quality, but there is also much concern about the very slow pace of actual implementation (see chapter 1 on infrastructure for more information on electronic health records). Privacy concerns will need to be addressed to implement either electronic health records or enhanced chronic illness registries. Again, in comparative effectiveness research, there will be winners (those whose procedures, drugs, or offered services are found to be most clinically effective) and losers (those who services are found to be less effective), and thus we can expect vigorous opposition from at least some quarters to a comprehensive approach.
ConClusIon
The United States has the largest economy in the world and the highest per capita health care costs, yet it consistently scores below other industrialized nations across several quality measures such as wait times to see physicians, life expectancy, mortality rates, coordination for chronic care, and deaths per capita from medical errors. We should not be outspending every country and still falling at or near the bottom across important quality measures. The American health care system needs a better return on its investment. Changing the way health care is conducted in our fragmented system will be difficult, and will require significant changes that demand political will. Nonetheless, if the new administration can meaningfully manage opposition to these systematic changes, it would radically improve our health care system. the Center for american Progress is a nonpartisan research and educational institute dedicated to promoting a strong, just and free america that ensures opportunity for all. We believe that americans are bound together by a common commitment to these values and we aspire to ensure that our national policies reflect these values. We work to find progressive and pragmatic solutions to significant domestic and international problems and develop policy proposals that foster a government that is "of the people, by the people, and for the people."
the Institute on Medicine as a Profession seeks to shape a world inside and outside of medicine that is responsive to the ideals of medical professionalism. IMaP supports research on the past, present, and future roles of medical professionalism in guiding individual and collective behavior. It aims to make professionalism in medicine relevant to physicians, leaders of medical organizations, policy analysts, public officials, and consumers.
